HSR25-154: Treatment Patterns and Prognosis of Patients With HER2-Negative Early Breast Cancer and Germline Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2
"HSR25-154: Treatment Patterns and Prognosis of Patients With HER2-Negative Early Breast Cancer and Germline Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Robert Wesolowski (ORCID: https://orcid.org/0000-0003-0606-0648)
- Andrea N. Riner (ORCID: https://orcid.org/0000-0003-2088-5400)
- Sagar Sardesai (ORCID: https://orcid.org/0000-0002-2688-0486)
- Bridget A. Oppong (ORCID: https://orcid.org/0000-0002-1696-4491)
- Vishnu Prasath (ORCID: https://orcid.org/0000-0002-4742-8552)
- Joanne Kim (ORCID: https://orcid.org/0000-0001-7458-2128)
- Akia Clark
- Kai Johnson
- Brandon Slover
Institutions
- The Ohio State University (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7256
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00